Medical Equipment

Internal Neuromodulation Devices Market Trends, Drivers, and Regional Analysis 2025–2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the internal neuromodulation devices market from 2025–2034 with trusted insights from The Business Research Company

How Is The Internal Neuromodulation Devices Market Size Expected To Expand Over 2029-2034?

The internal neuromodulation devices market has shown substantial growth in recent years. This market is anticipated to expand from $2.59 billion in 2024 to $2.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.0%. Historically, this growth has been driven by chronic pain management, an aging population, ongoing clinical research and trials, the prevalence of neurological disorders, and greater patient awareness and acceptance.

The internal neuromodulation devices market is projected to undergo significant expansion in the coming years, reaching a size of $3.87 billion by 2029, with a compound annual growth rate (CAGR) of 8.9%. This growth throughout the forecast period stems from factors such as personalized medicine trends, increasing healthcare expenditure, collaborations and partnerships, improvements in patient outcomes and real-world evidence, and changes in the regulatory landscape. Noteworthy trends during this period encompass miniaturization and implantable technology, wireless connectivity and remote monitoring, an expansion of neuromodulation applications, the development of closed-loop systems for precise modulation, and a strong focus on patient-centric design.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10222&type=smp

Which Market Factors Are Fueling The Internal Neuromodulation Devices Industry Growth?

The anticipated rise in neurologic disease cases is projected to propel the expansion of the internal neuromodulation devices market in the future. Neurologic diseases encompass a wide range of conditions impacting the nervous system, including the brain, spinal cord, and peripheral nerves throughout the body. Internal neuromodulation devices are medical instruments designed to address neurological and psychiatric issues through electrical stimulation delivered to precise nervous system regions, thereby alleviating symptoms like chronic pain, movement challenges, and mood disturbances. Such devices enhance patients’ quality of life by diminishing symptoms and facilitating easier engagement in daily tasks. For example, the National Library Medicine, a US-based biomedical library, stated in April 2023 that 6.7 million Americans were living with Alzheimer’s in 2023, a figure forecast to increase to 13.8 million by 2060. Furthermore, reports from the House of Lords Library, a UK-based information services firm, indicated in May 2022 that as of January 31, 2022, England’s neurology workforce comprised 1,638 full-time equivalent staff, representing an increase from 1,562 in 2021 and 1,468 in 2020. Consequently, the rising occurrence of neurologic diseases is a key factor propelling the expansion of the internal neuromodulation devices market.

Which Categories Are Covered In The Internal Neuromodulation Devices Market Segmentation Analysis?

The internal neuromodulation devicesmarket covered in this report is segmented –

1) By Type: Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator

2) By Technology Type: Internal Neuromodulation, External Neuromodulation

3) By Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials

4) By Application: Failed Back Surgery Syndrome, Parkinson’s Disease, Urinary Incontinence, Epilepsy, Gastroparesis

5) By End-User: Hospitals, Clinics, Home Healthcare, Community Healthcare

Subsegments:

1) By Spinal Cord Stimulator: Traditional Spinal Cord Stimulator, Rechargeable Spinal Cord Stimulator, Non-Rechargeable Spinal Cord Stimulator

2) By Deep Brain Stimulator: Single Lead Deep Brain Stimulator, Dual Lead Deep Brain Stimulator, Adaptive Deep Brain Stimulator

3) By Sacral Nerve Stimulator: Implantable Sacral Nerve Stimulator, External Sacral Nerve Stimulator

4) By Vagus Nerve Stimulator: Implantable Vagus Nerve Stimulator, Transcutaneous Vagus Nerve Stimulator

5) By Gastric Neuro Stimulator: Implantable Gastric Neuro Stimulator, External Gastric Neuro Stimulator

Which Market Trends Are Expected To Define The Future Of The Internal Neuromodulation Devices Market?

Product innovations are becoming a significant trend in the internal neuromodulation devices market. Leading companies in this segment are prioritizing the development of new technologies to maintain their competitive edge. For instance, in March 2023, Neuromod Device Ltd., an Ireland-based medical equipment manufacturer, announced that its Lenire system had been granted De Novo clearance by the US Food and Drug Administration (FDA). The Lenire system is designed to treat tinnitus, a neurological disorder marked by ringing in the ears, by combining sound and tongue stimulation. This system utilizes a dual-pronged approach to neurostimulation, where Bluetooth headphones emit unique sounds to stimulate the auditory nerve, and Neuromod’s Tonguetip device, placed in the mouth, delivers moderate electrical stimulation to the tongue’s surface. Otolaryngologists now have the ability to recommend this innovative Lenire technology to patients experiencing at least a moderately negative impact on their lives due to tinnitus.

Which Organizations Are At The Forefront Of The Internal Neuromodulation Devices Market?

Major companies operating in the internal neuromodulation devices market include Medtronic plc, Boston Scientific Corporation, BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, EnteroMedics Inc., LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/internal-neuromodulation-devices-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Internal Neuromodulation Devices Market?

North America was the largest region in the internal neuromodulation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10222&type=smp

Browse Through More Reports Similar to the Global Internal Neuromodulation Devices Market 2025, By The Business Research Company

Medical And Diagnostic Laboratory Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Magnetic Resonance Imaging Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795